USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
DETROIT R & D, INC.
Address:
2727 SECOND AVE., SUITE 4113
DETROIT, MI 48201-
Phone:
(248) 539-3236
URL:
N/A
EIN:
383375464
DUNS:
030673508
Number of Employees:
N/A
Woman-Owned?:
Yes
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,058,609.00 11
SBIR Phase II $2,453,631.00 4
STTR Phase I $434,586.00 1

Award List:

IMMUNOASSAY METABOLITES ARACHIDONIC ACID EPOXYGENASES

Award Year / Program / Phase:
1998 / SBIR / Phase I
Award Amount:
$99,788.00
Agency:
HHS
Principal Investigator:
Hyesook, Kim
Abstract:
N/a

N/A

Award Year / Program / Phase:
1999 / SBIR / Phase I
Award Amount:
$99,838.00
Agency:
HHS
Principal Investigator:
Hysook Kim
Abstract:
Not Available Thin film inflatable concentrators, via ground testing, have shown to be a viable alternative to current systems. Joint efforts between SRS, AFRL, Thiokol, and NASA have demonstrated the effectiveness of these technologies throough deployment, photogrammatic shape measurement, and… More

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Hysook Kim
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase II
Award Amount:
$599,743.00
Agency:
HHS
Principal Investigator:
Hysook Kim
Abstract:
N/a

N/A

Award Year / Program / Phase:
2001 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Abstract:
N/a

Mutagenicity/Genotoxicity with Endogenous PGH Synthase-2

Award Year / Program / Phase:
2001 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Hyesook S. Kim
Abstract:
N/a

Mutagenicity/Genotoxicity with Endogenous PGH Synthase-2

Award Year / Program / Phase:
2001 / SBIR / Phase II
Award Amount:
$376,240.00
Agency:
HHS
Principal Investigator:
Hyesook S. Kim
Abstract:
N/a

Fetal Alcohol Syndrome Biomarkers by Antibody Microarray

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$409,031.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Fetal Alcohol Syndrome (FAS) is defined as a pattern of growth retardation, characteristic facial anomalies and mental retardation in children born to alcoholic women. It is essential to begin remedial treatment of FAS children as early as possible. Therefore… More

"Xenopus Microarrays: A Tool for Molecular Toxicology"

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Each year, approximately 120,000 babies are born in the US with a major birth defect and genetic and environmental factors play an important role. Embryonic differentiation pathways are highly conserved among vertebrates. The Xenopus laevis embryo is an… More

"Xenopus Microarrays: A Tool for Molecular Toxicology"

Award Year / Program / Phase:
2003 / SBIR / Phase II
Award Amount:
$739,747.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Each year, approximately 120,000 babies are born in the US with a major birth defect and genetic and environmental factors play an important role. Embryonic differentiation pathways are highly conserved among vertebrates. The Xenopus laevis embryo is an… More

N/A

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$99,995.00
Agency:
HHS
Principal Investigator:
Kim Hyesook
Abstract:
N/a

Targeted Antibody Microarrays:Tool for Toxicoproteomics

Award Year / Program / Phase:
2005 / SBIR / Phase II
Award Amount:
$737,901.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Gene expression has been analyzed by throughput DMA microarrays which simultaneously monitor the expression of thousands of genes. However, mRNA expression of a gene may not correlate with protein expression because of the differences in rates of mRNA… More

Targeted Antibody Microarrays:Tool for Toxicoproteomics

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Gene expression has been analyzed by throughput DMA microarrays which simultaneously monitor the expression of thousands of genes. However, mRNA expression of a gene may not correlate with protein expression because of the differences in rates of mRNA… More

PHASE I TOPIC 196: ANTIBODY ARRAY FOR CANCER DETECTION

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$99,980.00
Agency:
HHS
Principal Investigator:
Hyesook Kim
Abstract:
N/a

Not Available

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$149,977.00
Agency:
HHS
Principal Investigator:
Kim Hysook
Abstract:
Not Available